Steven Laux

Steven Laux is an experienced executive in the analytics and commercial strategy sectors, currently serving as Vice President of Analytics and Head of the Generative AI Center of Excellence at Trinity Life Sciences since January 2024. Prior to this role, Steven was Vice President of Commercial Insights and Advanced Analytics at TGaS Advisors from September 2020 to December 2023. Steven's career includes significant positions at IQVIA as Principal, where development of machine learning and AI solutions for life science companies was a key responsibility, and at Windtree Therapeutics, Inc. as Head of Commercial Analytics. Steven also held director-level roles at GSK and marketRx, and was VP of Business Development at TargetRx. Additionally, Steven began a successful career at ZS Associates as a Manager specializing in healthcare strategy. Steven's educational background includes an MBA in Finance from The Wharton School and a BA from Colgate University.